Page 94 - AN-3-4

Advanced Neurology SARS-CoV-2 in age-associated neurodegeneration

42. Hosp JA, Reisert M, Dressing A, et al. Cerebral brain infection: Have we been barking up the wrong tree?
microstructural alterations in Post-COVID-condition are Mol Neurodegener. 2022;17(1):20.
related to cognitive impairment, olfactory dysfunction and doi: 10.1186/s13024-022-00529-9
fatigue. Nat Commun. 2024;15(1):4526.
54. Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central
doi: 10.1038/s41467-024-48651-0
nervous system involvement by severe acute respiratory
43. Spindler KR, Hsu TH. Viral disruption of the blood-brain syndrome coronavirus-2 (SARS-CoV-2). J Med Virol.
barrier. Trends Microbiol. 2012;20(6):282-290. 2020;92(7):699-702.
doi: 10.1016/j.tim.2012.03.009 doi: 10.1002/jmv.25915
44. Ayala-Nunez NV, Gaudin R. A viral journey to the brain: 55. Bentivoglio M, Kristensson K, Rottenberg ME.
Current considerations and future developments. PLoS Circumventricular organs and parasite neurotropism:
Pathog. 2020;16(5):e1008434. Neglected gates to the brain? Front Immunol. 2018;9:1-9.
doi: 10.1371/journal.ppat.1008434 doi: 10.3389/fimmu.2018.02877
45. Jackson CB, Farzan M, Chen B, Choe H. Mechanisms 56. Hernández-Parra H, Reyes-Hernández OD, Figueroa-
of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. González G, et al. Alteration of the blood-brain barrier by
2022;23(1):3-20. COVID-19 and its implication in the permeation of drugs
into the brain. Front Cell Neurosci. 2023;17:1125109.
doi: 10.1038/s41580-021-00418-x
doi: 10.3389/fncel.2023.1125109
46. Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions
of SARS-COV-2 with the blood-brain barrier. Int J Mol Sci. 57. Greene C, Connolly R, Brennan D, et al. Blood-brain
2021;22(5):2681. barrier disruption and sustained systemic inflammation
in individuals with long COVID-associated cognitive
doi: 10.3390/ijms22052681
impairment. Nat Neurosci. 2024;27(3):421-432.
47. Lima M, Siokas V, Aloizou AM, et al. Unraveling the possible
routes of SARS-COV-2 invasion into the central nervous doi: 10.1038/s41593-024-01576-9
system. Curr Treat Options Neurol. 2020;22(11):37. 58. Yang Q, Wang G, Zhang F. Role of peripheral immune cells-
mediated inflammation on the process of neurodegenerative
doi: 10.1007/s11940-020-00647-z
diseases. Front Immunol. 2020;11:582825.
48. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting doi: 10.3389/fimmu.2020.582825
enzyme 2 is a functional receptor for the SARS coronavirus.
Nature. 2003;426(6965):450-454. 59. Wentworth DE, Tresnan DB, Turner BC, et al. Cells of
human aminopeptidase N (CD13) transgenic mice are
doi: 10.1038/nature02145
infected by human coronavirus-229E in vitro, but not in
49. Bourgonje AR, Abdulle AE, Timens W, et al. Angiotensin- vivo. Virology. 2005;335(2):185-197.
converting enzyme 2 (ACE2), SARS-CoV-2 and the doi: 10.1016/j.virol.2005.02.023
pathophysiology of coronavirus disease 2019 (COVID-19).
J Pathol. 2020;251(3):228-248. 60. Li YC, Bai WZ, Hirano N, et al. Neurotropic virus tracing
suggests a membranous-coating-mediated mechanism
doi: 10.1002/path.5471
for transsynaptic communication. J Comp Neurol.
50. Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and 2013;521(1):203-212.
functional properties of SARS-CoV-2 spike protein: doi: 10.1002/cne.23171
Potential antivirus drug development for COVID-19. Acta
Pharmacol Sin. 2020;41(9):1141-1149. 61. Swain O, Romano SK, Miryala R, Tsai J, Parikh V,
Umanah GKE. SARS-CoV-2 neuronal invasion and
doi: 10.1038/s41401-020-0485-4
complications: Potential mechanisms and therapeutic
51. Essalmani R, Jain J, Susan-Resiga D, et al. Distinctive roles approaches. J Neurosci. 2021;41(25):5338-5349.
of furin and TMPRSS2 in SARS-CoV-2 infectivity. J Virol. doi: 10.1523/JNEUROSCI.3188-20.2021
2022;96(8):e0012822.
62. Butowt R, Bilinska K, von Bartheld CS. Olfactory
doi: 10.1128/jvi.00128-22
dysfunction in COVID-19: New insights into the underlying
52. Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 mechanisms. Trends Neurosci. 2023;46(1):75-90.
facilitates SARS-CoV-2 cell entry and infectivity. Science. doi: 10.1016/j.tins.2022.11.003
2020;370:856-860.
63. Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M,
doi: 10.1126/science.abd2985
Talbot PJ. Axonal transport enables neuron-to-neuron
53. Butowt R, von Bartheld CS. The route of SARS-CoV-2 to propagation of human coronavirus OC43. J Virol.

Volume 3 Issue 4 (2024) 21 doi: 10.36922/an.4267